GlassScriptPhysician profile
Winston Plunkett
NPI 1407351869
$1,227.29
in general payments reported to CMS, 2019-2025
21 companies · $335 in 2025
The $335 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $171 · 2022: $176 · 2023: $271 · 2024: $275 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $880.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $356.00 | 2021-2025 | Rybelsus, Ozempic |
| Novartis Pharmaceuticals Corporation | $228.13 | 2021-2025 | |
| Pfizer INC. | $124.90 | 2022-2024 | |
| Abbvie INC. | $111.66 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $58.23 | 2021-2023 | Xarelto |
| Lilly USA, LLC | $37.80 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $36.41 | 2024-2025 | |
| Exact Sciences Corporation | $31.47 | 2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $29.72 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $27.72 | 2022-2024 | Eliquis |
| Axsome Therapeutics, INC. | $23.07 | 2025 | Auvelity |
| Biohaven Pharmaceutical Holding Company LTD. | $22.33 | 2022 | |
| Stryker Corporation | $21.35 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Seqirus USA INC | $20.45 | 2025 | Fluad, Flucelvax |
| Boston Scientific Corporation | $19.07 | 2023 | Watchman Flx |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $17.05 | 2025 | Gvoke Hypopen |
| Amgen INC. | $15.95 | 2025 | Otezla, Repatha |
| Tactile Systems Technology INC | $14.25 | 2025 | Flexitouch Plus, Nimbl |
| Sanofi-Aventis U.S. LLC | $12.95 | 2023 | |
| Cvrx, INC. | $11.18 | 2024 | Barostim Neo System |
| Phathom Pharmaceuticals, INC. | $7.60 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Winston Plunkett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.